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Background: Clitoral reconstruction is a new surgical technique for women who have undergone female genital
mutilation/cutting (FGM/C). Objectives: To review evidence on the safety and efﬁcacy of clitoral reconstruction.
Search strategy: PubMed and Cochrane databases were searched for articles published in any language from
database inception until May 2014. Search terms related to FGM/C and clitoral reconstruction were used
in various combinations. Selection criteria: Studies of any design that reported on safety or clinical outcomes
(e.g. appearance, pain, sexual response, or patient satisfaction) associated with clitoral reconstruction after
FGM/C were included. Data collection and analysis: Evidence was summarized and systematically assessed via a
standard data abstraction form. Main results: Four of 269 identiﬁed articles were included. They were fair to
poor in quality. Summary measures could not be computed owing to heterogeneity. The studies reported on
immediate surgical complications, clitoral appearance, dyspareunia or chronic pain, and clitoral function
postoperatively via non-standardized scales. Conclusions: Women who request clitoral reconstruction should
be informed about the scarcity of evidence available. Additional research is needed on the safety and efﬁcacy
of the procedure to identify both long-term outcomes and which women might beneﬁt.
© 2015 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Clitoral reconstruction is a relatively new surgical technique that
was ﬁrst described by Thabet and Thabet [1], and subsequently by
others [2–7]. It has been reported to be a feasible and effective strategy
to reduce clitoral pain and improve sexual pleasure amongwomenwho
have undergone female genital mutilation/cutting (FGM/C) [2].
In African and high-resource countries, clitoral reconstruction is
increasingly advertised by the media as a strategy to restore sexual
pleasure and female identity, completeness, and dignity. In France, the
procedure has been covered by the national health insurance since
2004 to improve the sexuality, physical appearance, and pain of
women with FGM/C, and thousands of women have undergone the
surgery [2]. In Burkina Faso, there have been clitoral reconstruction
campaigns [6,8–12], including the building of hospitals dedicated to
this procedure [8–12]. Elsewhere, funding collections have been raised
to open centers of reconstructive surgery in Africa, Europe, Asia, and
the USA [13].
Despite the interest, advertising, and enthusiasm for this surgery,
clitoral reconstruction has not been widely investigated or adequately
evaluated for safety and efﬁcacy outcomes. Indeed, no ofﬁcial guidelines1211 Geneva, Switzerland.
lcadir).
and Obstetrics. Published by Elsevier Ior recommendations exist on clitoral reconstruction, which has
important surgical, psychosexual, and cultural implications [14]. Some
FGM/C experts have expressed concerns about the psychological
outcome, psychiatric morbidity, and potential harmful consequences
of the surgery [15,16].
Women’s sexuality is multifactorial and depends on the interaction
of anatomic, biochemical, neurophysiological, cognitive, relational,
cultural, and social and contextual factors [17,18]. The impact of the
different types of FGM/C on sexuality and orgasm is still unclear [19].
Furthermore, surgical interventions are not without risk: a thorough
understanding of the safety and efﬁcacy of clitoral reconstruction and
of the best care to offer is needed before services can be scaled up.
Therefore, the aim of the present study was to review evidence on the
safety and outcomes of clitoral reconstruction.2. Materials and methods
The present systematic review was conducted by following the
PRISMA guidelines [20]. The available literature on clitoral reconstruc-
tion after FGM/Cwas identiﬁed by searching the PubMed and Cochrane
databases for articles published in any language from the inception
of each database to May 31, 2014. The search terms used were
“female genital mutilation”, “female genital cutting”, “female genital
surgeries”, “FGM”, “FGC”, “FGM/C”, “clitoris”, “deﬁbulation”, and “clitoralreland Ltd. All rights reserved.
Table 2
Criteria for evaluating the internal validity of individual studies according to the United
States Preventive Services Task Force [21].a
Study design Criteria
Systematic
reviews
▪ Comprehensiveness of sources and search strategy used
▪ Standard appraisal of included studies
▪ Validity of conclusions
▪ Recentness and relevance
Case–control
studies
▪ Accurate ascertainment of cases
▪ Non-biased selection of cases and controls with exclusion
criteria applied equally to both
▪ Response rate
▪ Diagnostic testing procedures applied equally to each group
▪ Appropriate attention to potential confounding variables
RCTs and
cohort
studies
▪ For RCTs: adequate randomization, including concealment and
whether potential confounders were distributed equally among groups
▪ For cohort studies: consideration of potential confounders with
either restriction or measurement for adjustment in the analysis;
consideration of inception cohorts
▪ Maintenance of comparable groups (includes attrition,
crossovers, adherence, or contamination)
▪ Important differential loss to follow-up or overall high loss to follow-up
▪Measurements: equal, reliable, and valid (includes masking of outcome
assessment)
▪ Clear deﬁnition of interventions
▪ All important outcomes considered
▪ Analysis: adjustment for potential confounders for cohort
studies, or intention-to-treat analysis for RCTs
Diagnostic
accuracy
studies
▪ Screening test relevant, available for primary care, adequately
described
▪ Study uses a credible reference standard, performed irrespective
of test results
▪ Reference standard interpreted independently of screening test
▪ Handles indeterminate results in a reasonable manner
▪ Range of patients included in study
▪ Sample size
▪ Administration of reliable screening test
Abbreviation: RCT, randomized controlled trial.
a Reproduced from Harris et al. [21], by permission of Elsevier.
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identify additional studies, the bibliographies of retrieved studies
were manually reviewed.
Studies that reported on the safety or clinical outcomes (e.g. appear-
ance, pain, sexual response, or patient satisfaction) associated with
clitoral reconstruction after FGM/C were included. Studies reporting
on clitoral surgery not associated with FGM/C were excluded. All
study designs were eligible.
All authors participated in summarizing and systematically
assessing the evidence via the use of standard data abstraction forms.
The quality of each individual piece of evidence was assessed by using
the United States Preventive Services Task Force (USPSTF) grading
system (Tables 1 and 2) [21,22]. The USPSTF system considers both
the quality of the individual study and the body of evidence as a
whole. For each individual study, the USPSTF grade considers study
design (Table 1) and the internal validity of the study (Table 2). Internal
validity is a measure of howwell the studywas conducted and is scored
as good, fair, or poor (Table 2).
The presence of heterogeneity with respect to study design,
population characteristics, study population recruitment, extent of loss
to follow-up, and outcome measure deﬁnitions did not allow the
computation of summary measures of association for the outcomes of
studies included in the review.
3. Results
3.1. Identiﬁed studies
The search yielded 269 articles, of which four met the inclusion
criteria [1–4]. One was a case–control study [1] and the other three
were cohort studies of the safety and efﬁcacy of clitoral reconstruction
[2–4] (Table 3). The four studies reported data for a range of outcomes
including clitoral appearance, improved clitoral function, dyspareunia
and/or chronic vulvar pain, and orgasm and/or clitoral pleasure.
3.2. Safety
Three studies [2–4] reported on short-term surgical complications,
such as hematoma, wound breakdown, or fever. In the largest cohort
study of 2938 women [2], immediate complications after surgery were
noted for 155 (5.3%) patients, and 108 (3.7%) were readmitted to
hospital. In the case series of 453women from France [4], complications
were reported for 107 (23.6%) women, with a reoperation rate of 3.7%
and a readmission rate of 5.3%.
In the cohort of 94 women [3], immediate complications were
reported for 22 (23.4%) patients. Four women with wound dehiscence
underwent a second operation. Two long-term complications were
reported at 6 months: one woman developed a keloid scar and one de-
veloped hyperesthesia of the clitoris [3]. Nomortality or life-threatening
morbidity was reported.Table 1
Levels of evidence according to the United States Preventive Services Task Force [21,22].a
Level Origin of evidence
I Evidence obtained from at least one properly designed randomized
controlled trial
II-1 Evidence obtained fromwell designed controlled trials without randomization
II-2 Evidence obtained from well designed cohort or case–control analytic
studies, preferably from more than one center or research group
II-3 Evidence obtained frommultiple time series with or without the intervention
Marked results in uncontrolled experiments might also be regarded as this
type of evidence
III Opinions of respected authorities on the basis of clinical experience,
descriptive studies, or reports of expert communities
a Reproduced from Harris et al. [21], by permission of Elsevier.3.3. Postoperative clitoral appearance
Three of the studies reported whether a visible or palpable clitoris
was restored postoperatively [2–4]. Clitoral appearancewas categorized
as a normal clitoris, hoodless glans, visible projection, palpable projec-
tion, or no change. In the largest cohort study [2], 28% of women for
whom 1-year results were available had a normal clitoral appearance
at this stage. In the other cohort from France [4], 21% had a normal
clitoral appearance at 6 months of follow-up. In the third study [3],
3 (3.2%) of 94 patients had a normal clitoral appearance at 6 months.
All three studies were limited by high loss to follow-up (ranging
from 22% to 79%) and the fact that a subjective, non-validated scale
was used to assess clitoral appearance [2–4]. Furthermore, outcomes
were assessed by the operating surgeon, leading to a potential source
of bias [2–4].
3.4. Chronic vulvar pain or dyspareunia
Painwas evaluateddifferently in each study. In the largest cohort [2],
dyspareunia and chronic vulvar pain were assessed. Preoperatively, 28
(3%) of 840 women reported pain without sexual intercourse, and 202
(24%) reported moderate-to-severe pain with intercourse. Among
womenwho had pain without intercourse at baseline, 14 (50%) report-
ed at least slight improvement in their symptoms at 1 year of follow-up.
Among women reporting moderate-to-severe dyspareunia, 99 (49%)
reported at least slight improvement at 1 year of follow-up [2].
In another cohort study [4], 17 (4%) of 453 women reported
pain without sexual intercourse at baseline. Another 116 (25%)
had moderate-to-severe dyspareunia preoperatively. Postoperative
assessment of pain was not reported.
Table 3
Clitoral reconstruction outcomes.
Author,year Study design and population Intervention and follow-up Results Strengths Weaknesses Quality
Thabet and
Thabet,
2003 [1]
Case–control study at one center in
Egypt (n = 147)
Group 1: controls (n = 30)
Group 2: FGM/C type I (n = 30)
Group 3: FGM/C type II/III (n = 30)
Group 4: FGM/C of any type with
associated clitoral cysts (n = 57)
Groups 1 and 2: no intervention
Group 3: clitoral reconstruction
Group 4: clitoral reconstruction
and excision of a clitoral cyst
(30/57)a
Follow-up at 6 months
Safety: not reported
Postoperative clitoral appearance: not reported
Chronic pain/dyspareunia: not reported
Clitoral function: baseline/preoperative mean questionnaire score for sexual
function/orgasm 82.2 ± 1.5 in group 1, 78.9 ± 1.7 in group 2, 65.6 ± 1.7 in
group 3, 76.8 ± 2.0 in group 4; postoperative mean score 80.5 ± 1.7 in group
3 (P b 0.001), 63.0x ± 1.1 in group 4 with cyst excision alone (P b 0.001),
79.0 ± 1.1 in group 4 with cyst excision and clitoral reconstruction (P N 0.05)
Inclusion of a
control group
No sample size calculation
No data on the different types of FGM/C
Vulvar pain not explored
Non-validated questionnaire
Unknown loss to follow up
Unclear comparisons between groups
II-2
Poor
Foldès et al.,
2006 [4]
Prospective cohort at one center
in France (n = 453)
FGM/C type II or III (frequency of
each type not reported)
Clitoral reconstruction
Follow-up at 6 months
Safety: 23.6% (n = 107) had complications; 3.7% (n = 17) required
reoperation; 5.3% (n = 24) required readmission
Postoperative clitoral appearance: 37% (n = 168) had hoodless glans;
21% (n = 97) had “almost normal clitoris”
Chronic pain/dyspareunia: 4% (n= 17) pain without sexual intercourse and
25% (n = 116) moderate-to-severe dyspareunia preoperatively; not
reported postoperatively
Clitoral function: 19% (n = 84) slightly improved; 32% (n = 146)
signiﬁcantly improved without orgasms and 29% (n = 130) signiﬁcantly
improved with occasional orgasms; 14% (n = 65) normal clitoral function
– Non-validated scales with no clear deﬁnition
of categories
Results reported by surgeon
Surgical outcome evaluated as “clitoral
function” instead of pain, pleasure, orgasm, etc.
No data for the outcome of symptoms such as
dyspareunia or chronic vulvar pain
Unknown loss to follow up
No statistical comparisons
II-3
Poor
Foldès et al.
2012 [2]
Prospective cohort at one center
in France (n = 2938)
FGM/C type III (n = 146)
FGM/C type II (n = 2792)
Clitoral pain and functionality
evaluated at 1 year for 840 and
834 women, respectively
Clitoral reconstruction
Follow-up at 1 year
Safety: 5.3% (n = 155) had complications; reoperation rate not reported;
3.7% (n = 108) required readmission
Postoperative clitoral appearance: 42% (363/866) had hoodless glans;
28% (239/866) had normal clitoral appearance
Chronic pain/dyspareunia: 3% (28/840) had pain without intercourse and
24% (202/840) had moderate-to-severe pain with sexual intercourse
preoperatively; 50% (14/28) reported a slight or real improvement in pain
without intercourse and 49% (99/202) reported a slight or real
improvement in moderate-to-severe dyspareunia postoperatively
Clitoral function: 430 women reported “restricted or regular” orgasm
postoperatively; 129 of 368 who had never experienced orgasm reported
“restricted” or “regular” orgasms after surgery; 51 of 97 who had had
“restricted orgasms” preoperatively reported an improvement after
surgery; 12 of 53 women who had experienced regular orgasm reported an
orgasm of reduced intensity after surgery
– Non-validated scales with no clear deﬁnition
of categories
Results reported by surgeon
71% loss to follow-up at 1 year
Outcomes reported inconsistently among
population
II-3
Poor
Ouédraogo
et al.
2013 [3]
Prospective cohort at one center
in Burkina Faso (n = 94)
FGM/C type II (n = 89)
FGM/C type III (n = 5)
Clitoral reconstruction
Follow-up at 6 months
Safety: 23.4% (n = 22) reported immediate complications; 4.2% (n = 4)
required reoperation; readmission rate not reported; 2.1% (n = 2) had
long-term complications
Postoperative clitoral appearance: 3.2% (n = 3) had normal clitoral
appearance; 71.3% (n = 67) satisﬁed with appearance of the neoglans
Chronic pain/dyspareunia: 39.4% (n = 37) had dyspareunia and 5.4% (n = 5)
had superﬁcial dyspareunia preoperatively; not reported postoperatively
Clitoral function: 5.3% (n = 5) reported slight improvement; signiﬁcant
improvement without orgasms reported by 14.8% (n = 14) and with
occasional orgasms by 36.2% (n = 34); 38.3% (n = 36) reported normal
clitoral function; no signiﬁcant difference in orgasm before and after clitoral
reconstruction (P= 0.446)
– Non-validated scales with no clear deﬁnition
of each category
Results reported by surgeon
Patient satisfaction reported without
explaining how satisfaction was evaluated
Surgical outcome evaluated as “clitoral
function” instead of pain, pleasure, orgasm, etc.
No data concerning the outcome of single
symptoms
Unknown loss to follow-up
II-3
Poor
a Not speciﬁed why only 30 of the 57 women received the intervention.
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both dyspareunia and clitoral pleasure [3]. Preoperatively, moderate-
to-severe dyspareunia was noted for 37 of 94 women. Postoperative as-
sessment of pain was not reported separately from clitoral stimulation,
limiting interpretation of results.
3.5. Clitoral function
The case–control study from Egypt [1] investigated the sexual
function of women without FGM/C, women with FGM/C types II and
III, and women with any type of FGM/C who had an associated clitoral
cyst. A baseline assessment of sexual function was compared with
follow-up data at 6 months after surgery. The questionnaire included
data on “the state of the external and internal genitalia, the state of
femininity, the level of genital and sexual knowledge, sexual desire
and arousal, orgasm and sexual satisfaction” [1]. The responses were
used to generate a score out of 100. No deﬁnition of “normal” was
given for the responses pertaining to anatomy and femininity.
At 6 months after surgery, the scores had improved signiﬁcantly
among women with FGM/C type II/III who underwent clitoral
reconstruction (P b 0.001) and non-signiﬁcantly among those with
FGM/C of any type who underwent excision of a clitoral cyst and
clitoral reconstruction (Table 3). It is not known in which category
of the questionnaire (e.g. anatomy knowledge or sexual satisfaction)
that the scores changed. The clinical relevance of the scores
is unknown.
Three studies reported measures of clitoral function as assessed by
orgasm, sexual pleasure, or desire [2–4]. All three studies used a ﬁve-
point, non-validated scale to assess clitoral pleasure. In terms of clitoral
pleasure, women were categorized as never (no sensation), minor
sensation, pleasant without orgasm, restricted orgasm (orgasm with
less intensity than wished), and regular orgasm (“normal” orgasm).
No deﬁnition of “normal” orgasm was given.
Foldès et al. [2] reported that 385 (46%) of 834 women had a slight
or real improvement in clitoral pleasure 1 year after surgery and 430
(51%) women described experiencing restricted (n = 255) or normal
(n = 175) orgasms at 1 year of follow-up [2]. Among 53 women who
had experienced regular orgasms preoperatively, however, 12 reported
a reduction in intensity after surgery [2].
Another cohort study [4] reported that 173 (38%) of 453women had
never experienced clitoral pleasure, whereas 10 (2%) had restricted or
normal orgasms at baseline. Postoperatively, 230 (51%) endorsed slight
or real improvement in clitoral pleasure, without orgasm. Another
195 (43%) patients described having restricted/occasional orgasms
(n = 130) or normal orgasms (n = 65) [4]. The study was limited by
the absence of statistical comparisons.
Ouédraogo et al. [3] reported data on preoperative sexual desire and
clitoral pleasure in their case series. At baseline, 41.5% (39/94) of partic-
ipants reported never feeling any sexual desire [3]. With respect to
clitoral pleasure, 54.3% (51/94) described no sensation, whereas 12.7%
(12/94) had restricted or regular orgasms [3]. After surgery, only 5.3%
(5/94) of women reported no sexual desire. The study was also limited
by the absence of statistical comparisons.
Interpretation of theﬁndings from the three cohort studies is limited
by the use of non-validated scales and the fact that the results were
recorded by the operating surgeon [2–4], which introduces two poten-
tial sources of bias to all three studies.
4. Discussion
The present study has systematically reviewed published studies on
clitoral reconstruction—a practice that is growing in popularity. A
limited amount of poor evidence is available on clitoral reconstruction
after FGM/C. There is a need for more robust evidence on safety and
efﬁcacy before this surgery is widely disseminated. Data that identify
how therapy—either alone or in combination with surgery—canimprove psychosexual outcomes for women living with FGM/C is
urgently needed. An improved understanding of how this surgery
affects gender identity, pain, and sexual pleasure is required to identify
the women who might beneﬁt from it, and those for whom alternative
therapy is indicated.
Three of the studies included in the present review [2–4] were
limited by not having a comparison group. All the studies [1–4] are
limited by a large or unknown loss to follow-up in the cohort, and by
a follow-up period of 1 year or less. There are additional key limitations
in how the studies evaluated and reported outcomes. Some assessed the
anatomic postoperative result only from the surgeon’s point of view
[2–4], and studied preoperative and postoperative pain [2–4], orgasm,
and clitoral pleasure [1–4] by empirical, non-validated scales. Although
three studies [2–4] endorse the importance ofmultidisciplinary psycho-
sexual care, the women included in them were evaluated, treated, and
followed up only by the surgeon. The reports stated that the surgeon
might refer some women to a psychologist, psychiatrist, or sexologist
to assist with their care when deemed necessary; however, no data
were reported on the number of women who asked for, were offered,
or accepted psychosexual therapy [2–4]. None of the four studied
evaluated the impact of sexual therapy and education (on reducing
pain or improving sexual outcomes), either alone or in association
with clitoral reconstruction.
Female sexuality is multifactorial, and clitoral reconstruction has
surgical, sociocultural, gender, anthropologic, and psychosexual impli-
cations. It is crucial to associate and study the effects of psychosexual
care and education on female physiology, anatomy, and sexuality [14].
Resection of the clitoral ﬁbrosis and easier access to the clitoris might
potentially improve pleasure and pain; however, existing data are
inconclusive [14]. Gender identity and body image also play a determi-
nant role in sexuality, and these interactionsneed to be investigated and
addressed within the context of this surgery. A study of the histology of
the peri-clitoral scar removed during surgery might clarify whether the
resection of eventual post-traumatic granulomas and neuromas can
resolve chronic clitoral pain. Such data might help to determine which
women would beneﬁt from surgery.
Current advertising campaigns are generating a considerable
demand for clitoral reconstruction, despite the absence of conclusive
evidence regarding its beneﬁts or absence of harm. The impact of the
different types of FGM/C on sexuality and orgasm is still unclear [19].
Young women, who might not even have started their sexual life,
might assume that they need the surgery both to be “normal” and to
have sexual pleasure. Basic anatomy lessons and sexual therapy could
have an important role to play. Many women with FGM/C and their
partners do not know that most of or even the whole clitoris is under
the scar and can be stimulated. They could think that they do not have
sexual pleasure only because they have been cut, or they could assume
that, when sexual pleasure is present, their intercourse is less satisfying
than is that of uncut women [14].
Further studies—ideally prospective, multicenter, comparative
trials—should focus on preoperative and postoperative sexual desire,
sexual pleasure, orgasm, vulvar pain, self body image, and gender
identity. Validated or standardized tools should be implemented and
used. Assessment of the surgery should include long-term follow-up
of women who have and have not undergone the procedure. Preoper-
ative expectations, self-anatomy, and physiology knowledge and
beliefs, in addition to postoperative satisfaction, should be explored
[14]. Robust evidence is needed to evaluate the efﬁcacy and long-
term outcomes of this surgery.
In summary, women who want to undergo clitoral reconstruction
should be informed about the scarcity of evidence that is available on
improved outcomes. A better understanding of how both surgery and
sexual therapy with anatomy lessons might improve sexuality and
body image is necessary. A comprehensive, evidence-based approach
that does not contribute to stigmatization of women and girls living
with FGM/C is needed to provide optimal care.
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